Table 2 Analysis of BTcP groups
Variable | No BTcP n = 36 | BTcP n = 28 | No BTcP vs. BTcPa |
|---|---|---|---|
Age | 0.760 | ||
Mean (SD) | 59.7 (14.8) | 61.7 (11.1) | |
BMI | 0.180 | ||
Mean (SD) | 25.7 (4.2) | 24.1 (4.8) | |
Comorbidities | 0.636 | ||
None | 16 (44%) | 15 (54%) | |
≥ 1 | 20 (56%) | 13 (46%) | |
ECOG | < 0.001 | ||
< 3 | 32 (89%) | 12 (43%) | |
> 2 | 4 (11%) | 16 (57%) | |
CDA | 0.808 | ||
Mean (SD) | 0.1 (0.2) | 0.1 (0.1) | |
TTP | 0.556 | ||
Mean (SD) | 0.1 (0.1) | 0.1 (0.1) | |
SDRR | 0.962 | ||
Mean (SD) | 59.3 (64.2) | 53.7 (52.7) | |
SDHR | 0.984 | ||
Mean (SD) | 6.9 (7.8) | 5.9 (6.3) | |
Metastasis | 0.117 | ||
No | 20 (56%) | 10 (36%) | |
Yes | 8 (22%) | 5 (18%) | |
Bone | 8 (22%) | 13 (46%) | |
Chemotherapy | 0.099 | ||
No | 24 (67%) | 12 (43%) | |
Yes | 12 (33%) | 16 (57%) | |
Surgery | > 0.999 | ||
No | 31 (86%) | 24 (86%) | |
Yes | 5 (14%) | 4 (14%) | |
Radiotherapy | 0.544 | ||
No | 28 (78%) | 19 (68%) | |
Yes | 8 (22%) | 9 (32%) | |
Adjuvants | > 0.999 | ||
No | 22 (61%) | 18 (64%) | |
Yes | 14 (39%) | 10 (36%) | |
Opioids | 0.027 | ||
No | 12 (33%) | 2 (7%) | |
Yes | 24 (67%) | 26 (93%) | |
Cancer Type | 0.842 | ||
Other | 15 (42%) | 8 (29%) | |
Gastrointestinal | 5 (14%) | 6 (21%) | |
Breast | 3 (8%) | 3 (11%) | |
Bone/soft tissue | 7 (19%) | 6 (21%) | |
Lung | 6 (17%) | 5 (18%) |